Why are women with ST-elevation myocardial infarction treated differently to men?

Andrew I MacIsaac and Gemma Figtree
Med J Aust 2018; 209 (3): . || doi: 10.5694/mja18.00476
Published online: 6 August 2018

STEMI and coronary artery disease are major but underappreciated killers of Australian women

This issue of the Journal includes confronting data about inequities in the treatment and outcomes for men and women with ST-elevation myocardial infarction (STEMI).1 Khan and colleagues report that the 6-month mortality for women presenting with STEMI is twice that of men, a difference that persists after statistical correction for age and comorbid conditions. The article relates worrying evidence of a disparity in the delivery of evidence-based treatment, raising many important questions: What barriers are preventing women from presenting for treatment earlier? Why are there delays in providing women with recognised life-saving treatments? Why are women as a group treated less intensively than men despite having higher Global Registry of Acute Coronary Events (GRACE) risk scores? What biological differences require distinct therapeutic approaches and dedicated clinical trials?

  • Andrew I MacIsaac1
  • Gemma Figtree2

  • 1 St Vincent's Hospital Melbourne, Melbourne, VIC
  • 2 Kolling Institute of Medical Research, Sydney, NSW


Competing interests:

No relevant disclosures.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.